168 related articles for article (PubMed ID: 18285676)
1. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far?
Sorrentino D
Digestion; 2008; 77(1):38-47. PubMed ID: 18285676
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Lichtenstein GR; Olson A; Travers S; Diamond RH; Chen DM; Pritchard ML; Feagan BG; Cohen RD; Salzberg BA; Hanauer SB; Sandborn WJ
Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
[TBL] [Abstract][Full Text] [Related]
3. Infliximab in Crohn's disease: a look at the (not so distant) future.
Sorrentino D; Terrosu G; Avellini C
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S229-35. PubMed ID: 18598994
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment for symptomatic Crohn's disease strictures.
Pelletier AL; Kalisazan B; Wienckiewicz J; Bouarioua N; Soulé JC
Aliment Pharmacol Ther; 2009 Feb; 29(3):279-85. PubMed ID: 19035967
[TBL] [Abstract][Full Text] [Related]
5. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
6. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
7. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
Moss AC; Treister NS; Marsee DK; Cheifetz AS
Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
[No Abstract] [Full Text] [Related]
8. Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease--modelling outcomes in active luminal and fistulizing disease in adults.
Lindsay J; Punekar YS; Morris J; Chung-Faye G
Aliment Pharmacol Ther; 2008 Jul; 28(1):76-87. PubMed ID: 18410558
[TBL] [Abstract][Full Text] [Related]
9. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
10. Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.
Szabò H; Fiorino G; Spinelli A; Rovida S; Repici A; Malesci AC; Danese S
Aliment Pharmacol Ther; 2010 Jan; 31(2):189-201. PubMed ID: 19832726
[TBL] [Abstract][Full Text] [Related]
11. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
Gisbert JP; Panés J
Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
[TBL] [Abstract][Full Text] [Related]
12. Infliximab in Crohn's disease: early and long-term treatment.
Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
[TBL] [Abstract][Full Text] [Related]
13. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
15. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
Sorrentino D; Terrosu G; Vadalà S; Avellini C
Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
[No Abstract] [Full Text] [Related]
16. Medical management of Crohn's disease: a guide for radiologists.
Helper DJ
Eur J Radiol; 2009 Mar; 69(3):371-4. PubMed ID: 19223133
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease.
D'Amico F; Pugliese N; Peyrin-Biroulet L; Danese S
Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):347-353. PubMed ID: 32351139
[TBL] [Abstract][Full Text] [Related]
18. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
Martín De Carpi J; Varea V
An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of the endoscopic treatment of strictures in pediatric and adult patients with inflammatory bowel disease.
Foster EN; Quiros JA; Prindiville TP
J Clin Gastroenterol; 2008 Sep; 42(8):880-5. PubMed ID: 18645528
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy for Crohn's disease: top-down or step-up?
Baert F; Caprilli R; Angelucci E
Dig Dis; 2007; 25(3):260-6. PubMed ID: 17827952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
